Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Colls

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|September 19, 2000
Tumour markers in malignancies. Monocolonal immunoglobulin and beta human chorionic gonadotrophinB M Colls
British Journal of Cancer|April 1, 1991
Frequency of serum tumour marker monitoringB M Colls
British Journal of Cancer|December 1, 1994
Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)B M Colls
Internal Medicine Journal|October 7, 2005
Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospitalB M Colls
Lancet (London, England)|May 31, 1980
Cannabis and cancer chemotherapyB M Colls
The New Zealand Medical Journal|June 28, 1978
The management of Hodgkin's disease in a regional centre over an eight-year periodB M Colls
BMJ (Clinical Research Ed.)|February 5, 1994
Improving the preregistration experience: the New Zealand approachP I Allen, B M Colls
The New Zealand Medical Journal|July 13, 1983
Advances in the management of testis tumoursE P Arnold, B M Colls
The New Zealand Medical Journal|December 1, 1970
Monoclonal gammopathy: study of 52 casesB M Colls, R W Carrell
Diseases of the Colon and Rectum|April 7, 2005
Hyponatremia and seizures after bowel preparation: report of three casesF A Frizelle, B M Colls
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|September 19, 2000
Tumour markers in malignancies. Monocolonal immunoglobulin and beta human chorionic gonadotrophinB M Colls
British Journal of Cancer|April 1, 1991
Frequency of serum tumour marker monitoringB M Colls
British Journal of Cancer|December 1, 1994
Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)B M Colls
Internal Medicine Journal|October 7, 2005
Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospitalB M Colls
Lancet (London, England)|May 31, 1980
Cannabis and cancer chemotherapyB M Colls
The New Zealand Medical Journal|June 28, 1978
The management of Hodgkin's disease in a regional centre over an eight-year periodB M Colls
BMJ (Clinical Research Ed.)|February 5, 1994
Improving the preregistration experience: the New Zealand approachP I Allen, B M Colls
The New Zealand Medical Journal|July 13, 1983
Advances in the management of testis tumoursE P Arnold, B M Colls
The New Zealand Medical Journal|December 1, 1970
Monoclonal gammopathy: study of 52 casesB M Colls, R W Carrell
Diseases of the Colon and Rectum|April 7, 2005
Hyponatremia and seizures after bowel preparation: report of three casesF A Frizelle, B M Colls
Pageof 6